Listed

Champions Oncology, Inc.: Form 10-Q for the period ended Jan 31, 2012

Filed with the SEC on Mar 14, 2012 and accepted by EDGAR at Mar 14, 2012, 14:58 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2012-01-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Research and development3 months2011-11-01 to 2012-01-31$930.0kus-gaap:ResearchAndDevelopmentExpense
Research and development9 months2011-05-01 to 2012-01-31$2.6mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2011-11-01 to 2012-01-31−$1.8mus-gaap:OperatingIncomeLoss
Operating income9 months2011-05-01 to 2012-01-31−$6.5mus-gaap:OperatingIncomeLoss
Income tax3 months2011-11-01 to 2012-01-31$0us-gaap:IncomeTaxExpenseBenefit
Income tax9 months2011-05-01 to 2012-01-31$0us-gaap:IncomeTaxExpenseBenefit
Net income3 months2011-11-01 to 2012-01-31−$1.7mus-gaap:NetIncomeLoss
Net income9 months2011-05-01 to 2012-01-31−$6.1mus-gaap:NetIncomeLoss
Diluted EPS3 months2011-11-01 to 2012-01-31−$0.04us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS9 months2011-05-01 to 2012-01-31−$0.13us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow9 months2011-05-01 to 2012-01-31−$3.7mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2011-05-01 to 2012-01-31$371.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Share repurchases9 months2011-05-01 to 2012-01-31$0us-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2012-01-31$6.5mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2012-01-31$7.6mus-gaap:AssetsCurrent
Total assetsAt period end2012-01-31$8.9mus-gaap:Assets
Current liabilitiesAt period end2012-01-31$3.5mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2012-01-31$4.1mus-gaap:Liabilities
Shareholders' equityAt period end2012-01-31−$3.4mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001144204-12-014815. Last ingested by Listed: Nov 10, 2026, 03:33 ET. Listed shows no prices and gives no investment advice.